Topical roflumilast formulation having improved delivery and plasma half-life | Patent Publication Number 20230364066
US 20230364066 A1Patent NumberUS 12005052 B2
Application Number18353869
Filled DateJul 17, 2023
Priority DateJun 7, 2017
Publication DateNov 16, 2023
Original AssigneeArcutis Biotherapeutics Inc.
Current AssigneeIplg Llp
Inventor/ApplicantsDavid W. OSBORNE
David W. Osborne
David W. Osborne
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.